Latest stories on MIRA
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
Mira Pharmaceuticals reports positive preclinical data for MIRA-55
The Fly63 · neutralproduct/pr
MIRA Pharmaceuticals Reports Positive Preclinical Results for MIRA-55
TipRanks64 · neutralproduct/pr
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA Pharmaceuticals Reports MIRA-55 Demonstrated Significant Pain Relief Comparable to Celebrex in Chronic Inflammatory Pain Study
Business Insider64 · neutralproduct/pr
MIRA Pharmaceuticals Reports MIRA-55 Demonstrated Significant Pain Relief Comparable to Celebrex in Chronic Inflammatory Pain Study
GlobeNewswire64 · neutralproduct/pr
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review
StockTitan63 · neutralproduct/pr
MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review
GlobeNewswire67 · bullishproduct/pr
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA-55 toxicology results advance non-opioid pain program
TipRanks67 · bullishproduct/pr
Mira Pharmaceuticals announces results from MIRA-55 studies
The Fly55 · neutralproduct/pr
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND
Business Insider63 · neutralproduct/pr
MIRA Reports Positive Preclinical Results for Obesity Candidate SKNY-1
TipRanks63 · neutralproduct/pr
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA Reports Positive 7-Day Dog Study Results for SKNY-1
StockTitan63 · neutralproduct/pr
MIRA Pharmaceuticals Receives Nasdaq Minimum Bid Price Notice
TipRanks34 · bearishgeneral
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K28 · bearishgeneral
MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies
StockTitan63 · neutralproduct/pr
MIRA Pharmaceuticals announces positive preclinical results for MIRA-55
TipRanks63 · neutralproduct/pr
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA Reports Positive Preclinical Data for SKNY-1 Program
TipRanks63 · neutralproduct/pr